SOUTH SAN FRANCISCO, Calif., May 6, 2013 (GLOBE NEWSWIRE) -- Hyperion Therapeutics, Inc. (Nasdaq:HPTX) today announced that it will report financial results for the first quarter 2013 ended March 31, 2013, after market closes on Thursday, May 9, 2013. Hyperion will host a webcast and conference call with management to discuss financial results, as well as provide a general corporate update, at 4:30 p.m. EDT (1:30 p.m. PDT). A live audio webcast of the conference call can be accessed on Hyperion's investor relations website at: http://investors.hyperiontx.com/events.cfm To access the live conference call, dial 877-847-7188 U.S. or 408-427-3787 International and use the conference ID# 46599927. A replay of the call will be available for 30 days by accessing Hyperion's investor relations website or by dialing 855-859-2056 U.S. or (404) 537-3406 International and use conference ID# 46599927 beginning approximately one hour after the conference call concludes. About Hyperion Therapeutics Hyperion Therapeutics, Inc. is a commercial stage biopharmaceutical company committed to developing and delivering life-changing treatments for orphan diseases and hepatology.
CONTACT: Myesha Edwards, Investor Relations (650) 745-7829 firstname.lastname@example.org Kristie Kuhl, Media Relations (203) 556-7417 email@example.com